Korean Drug Co., Ltd. (KOSDAQ:014570)
3,405.00
+5.00 (0.15%)
At close: Aug 21, 2026
Korean Drug Market Cap
Korean Drug has a market cap or net worth of 37.16 billion as of August 21, 2026. Its market cap has decreased by -26.70% in one year.
Market Cap
37.16B
Enterprise Value
840.49M
Revenue
65.39B
Ranking
n/a
PE Ratio
25.08
Stock Price
3,405.00
ChartMarket Cap Chart
Since March 31, 2005, Korean Drug's market cap has increased from 12.54B to 37.16B, an increase of 196.29%. That is a compound annual growth rate of 5.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 37.16B | -20.81% |
| Dec 30, 2025 | 46.92B | -6.42% |
| Dec 30, 2024 | 50.14B | -36.00% |
| Dec 28, 2023 | 78.35B | -8.30% |
| Dec 29, 2022 | 85.44B | -12.32% |
| Dec 30, 2021 | 97.44B | -13.30% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BL Pharmtech | 54.06B |
| Jin Yang Pharmaceutical | 50.93B |
| Samik Pharmaceutical Company LTD. | 49.58B |
| RP Bio | 48.44B |
| Organoidsciences | 45.44B |
| GeneBioTech Co. ,Ltd | 40.17B |
| Eagle Veterinary Technology Co.,Ltd | 38.68B |
| Korea Arlico Pharm | 36.17B |